Literature DB >> 3810792

Lassa fever in children in Sierra Leone, West Africa.

P A Webb, J B McCormick, I J King, I Bosman, K M Johnson, L H Elliott, G K Kono, R O'Sullivan.   

Abstract

A systematic study of Lassa fever in febrile children was undertaken over a four-year period, from August 1977 to August 1981, in the Eastern Province of Sierra Leone, West Africa. 479 patients were studied; of these, 245 had adequate specimens to confirm or exclude the laboratory diagnosis of Lassa fever. 51 cases of Lassa fever were identified (21% of patients from whom diagnosis was possible). Virus was isolated from 23 patients. All children had fever; cough and vomiting were present in over 60% of cases studied. The five to nine-year age group had the highest prevalence rate (41% of cases). Seasonal clustering occurred in April, May, and August. A significantly higher proportion of females than males had Lassa fever, a finding which remains to be explained. It is concluded that Lassa fever is a disease of significant concern in the paediatric age group.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3810792     DOI: 10.1016/0035-9203(86)90147-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.

Authors:  Danny A Asogun; Donatus I Adomeh; Jacqueline Ehimuan; Ikponmwonsa Odia; Meike Hass; Martin Gabriel; Stephan Olschläger; Beate Becker-Ziaja; Onikepe Folarin; Eric Phelan; Philomena E Ehiane; Veritas E Ifeh; Eghosasere A Uyigue; Yemisi T Oladapo; Ekene B Muoebonam; Osagie Osunde; Andrew Dongo; Peter O Okokhere; Sylvanus A Okogbenin; Mojeed Momoh; Sylvester O Alikah; Odigie C Akhuemokhan; Peter Imomeh; Maxy A C Odike; Stephen Gire; Kristian Andersen; Pardis C Sabeti; Christian T Happi; George O Akpede; Stephan Günther
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

2.  Lassa fever in post-conflict sierra leone.

Authors:  Jeffrey G Shaffer; Donald S Grant; John S Schieffelin; Matt L Boisen; Augustine Goba; Jessica N Hartnett; Danielle C Levy; Rachael E Yenni; Lina M Moses; Mohammed Fullah; Mambo Momoh; Mbalu Fonnie; Richard Fonnie; Lansana Kanneh; Veronica J Koroma; Kandeh Kargbo; Darin Ottomassathien; Ivana J Muncy; Abigail B Jones; Megan M Illick; Peter C Kulakosky; Allyson M Haislip; Christopher M Bishop; Deborah H Elliot; Bethany L Brown; Hu Zhu; Kathryn M Hastie; Kristian G Andersen; Stephen K Gire; Shervin Tabrizi; Ridhi Tariyal; Mathew Stremlau; Alex Matschiner; Darryl B Sampey; Jennifer S Spence; Robert W Cross; Joan B Geisbert; Onikepe A Folarin; Christian T Happi; Kelly R Pitts; F Jon Geske; Thomas W Geisbert; Erica Ollmann Saphire; James E Robinson; Russell B Wilson; Pardis C Sabeti; Lee A Henderson; S Humarr Khan; Daniel G Bausch; Luis M Branco; Robert F Garry
Journal:  PLoS Negl Trop Dis       Date:  2014-03-20

3.  A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.

Authors:  Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby
Journal:  BMC Med       Date:  2019-06-11       Impact factor: 8.775

Review 4.  Viral hemorrhagic fevers: current status of endemic disease and strategies for control.

Authors:  Dennis J Cleri; Anthony J Ricketti; Richard B Porwancher; Luz S Ramos-Bonner; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2006-06       Impact factor: 5.982

5.  Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.

Authors:  Laura Merson; Josephine Bourner; Sulaiman Jalloh; Astrid Erber; Alex Paddy Salam; Antoine Flahault; Piero L Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2021-09-21

Review 6.  Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.

Authors:  Hannah L Murphy; Hinh Ly
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 7.  Multifunctional nature of the arenavirus RING finger protein Z.

Authors:  Sarah Katharina Fehling; Frank Lennartz; Thomas Strecker
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

8.  Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus.

Authors:  Fatih M Uckun; Alexander S Petkevich; Alexei O Vassilev; Heather E Tibbles; Leonid Titov
Journal:  BMC Infect Dis       Date:  2004-01-13       Impact factor: 3.090

9.  Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area.

Authors:  Odigie C Akhuemokhan; Rosemary O Ewah-Odiase; Nosa Akpede; Jacqueline Ehimuan; Donatus I Adomeh; Ikpomwonsa Odia; Sylvia C Olomu; Meike Pahlmann; Beate Becker-Ziaja; Christian T Happi; Danny A Asogun; Sylvanus A Okogbenin; Peter O Okokhere; Osagie S Dawodu; Irekpono U Omoike; Pardis C Sabeti; Stephan Günther; George O Akpede
Journal:  PLoS Negl Trop Dis       Date:  2017-07-03

Review 10.  Arenaviruses.

Authors:  J P Gonzalez; S Emonet; X de Lamballerie; R Charrel
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.